Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.
about
Identification of a gene expression driven progression pathway in myxoid liposarcoma.Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcomaPrognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis.Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell linesPrognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomasHSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.Cancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma.Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.Liposarcoma: molecular genetics and therapeutics.SRC inhibition represents a potential therapeutic strategy in liposarcoma.Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and casein kinase II inhibition as a potential treatment option.Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy.Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas.Tumour-associated macrophages correlate with poor prognosis in myxoid liposarcoma and promote cell motility and invasion via the HB-EGF-EGFR-PI3K/Akt pathways.Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations.The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma.NY-ESO-1 (CTAG1B) expression in mesenchymal tumors.Myxoid Liposarcoma: Prognostic Factors and Metastatic Pattern in a Series of 148 Patients Treated at a Single Institution.
P2860
Q34227540-08EB7495-284A-479F-AC14-7FC2DC19FA61Q35700114-14C8786A-3EDA-4986-8E83-10B41ADFBE00Q35915343-10D74679-1E7E-42DC-A34C-F5DA18A1C917Q36438319-38181A52-8A13-4B97-A5DE-7A537BE9C4CBQ36629530-084F5336-C30D-46C8-B576-36392862FDABQ36729440-518D1BC3-0A50-4EB2-9A86-CC8AF259DE4CQ37082518-9C242AB9-4AE4-4000-86FA-AE78D57740D9Q37136357-1251C557-C1A7-48C6-BB10-0C475BD5657BQ37831160-735327AF-2E79-475F-BE24-4F0989E015C5Q38862860-AA2C6CBE-B212-4EEF-A34A-B7374B362EDAQ39652400-768002FE-2C12-45A2-A0F2-8B3149485F71Q41050294-CBC0A4D6-8513-4CAE-B5C5-EB512DC9188DQ41764961-75D2FDE8-CBBC-4260-BAE2-4EE322734E55Q42275473-52C02821-A911-4854-82CD-FAA512D71497Q46468034-6D163ABF-75BE-4EC9-BD10-604B6FF85C64Q50420957-2202D0E2-6C0E-4638-BBEB-583D9F3B020FQ53081281-4EA16319-2D07-4387-943D-AE1BAFF2EDBDQ55427534-527F23F0-BEF7-43FB-B8D4-402EC2E2D87E
P2860
Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Validation of immature adipoge ...... coma using tissue microarrays.
@en
Validation of immature adipoge ...... coma using tissue microarrays.
@nl
type
label
Validation of immature adipoge ...... coma using tissue microarrays.
@en
Validation of immature adipoge ...... coma using tissue microarrays.
@nl
prefLabel
Validation of immature adipoge ...... coma using tissue microarrays.
@en
Validation of immature adipoge ...... coma using tissue microarrays.
@nl
P2093
P1433
P1476
Validation of immature adipoge ...... coma using tissue microarrays.
@en
P2093
Erika Mehl
Hongwei Cheng
Neal Poulin
Shuzhen Liu
Torsten O Nielsen
P304
P356
10.1016/J.HUMPATH.2009.01.011
P407
P577
2009-04-14T00:00:00Z